Membrane bioreactor for treatment of pharmaceutical wastewater containing acetaminophen Original Research Article

Treatment of pharmaceutical wastewater is a real challenge for wastewater engineers. In this study, a pilot-scale system including an external loop airlift membrane bioreactor (ELAMBR) was applied for treatment of a synthetic pharmaceutical wastewater. The performance of this system was evaluated in removal of acetaminophen as the main pollutant of a pharmaceutical wastewater. A conventional activated sludge (CAS process) laboratory system was used in parallel with this system to compare both systems in regard to their ability for acetaminophen removal. The performance of the ELAMBR system was monitored for approximately one month to investigate the long-term operational stability of the system and possible effects of solids retention time on the efficiency of removal of acetaminophen. The removal efficiency was significantly higher in the ELAMBR system than the CAS process. 100% of the acetaminophen was removed after 2 days in this system. The results also showed that initial concentration of acetaminophen, chemical oxygen demand (COD) and mixed liquid suspended solids (MLSS) are the most effective parameters in removal of a pollutant such as acetaminophen. This study demonstrates the usefulness of ELAMBR system for pharmaceutical wastewater treatment with the advantages such as: (i) simple operation and maintenance, (ii) efficient removal of pharmaceutical pollutant and COD and (iii) low-energy consumption.